Center for Technology Transfer & Commercialization (CTTC)

Electrical circuit with various components interfaced with a brain
December 6, 2016

Blood-brain barrier on a chip sheds new light on “silent killer”

A new microfluidic device containing human cells that faithfully mimics the behavior of the blood-brain barrier is providing new insights into brain inflammation, the silent killer.

By VUMC News and Communications
May 5, 2016

Current cancer drug discovery method flawed: VUMC study

The primary method used to test compounds for anti-cancer activity in cells is flawed, Vanderbilt University researchers reported May 2 in Nature Methods.

By Leigh MacMillan
February 1, 2016

Successful entrepreneur and innovator chosen to lead new Innovation Center

Startup veteran Robert Grajewski has been chosen as the inaugural executive director of the newly created Vanderbilt University Innovation Center.

By VUMC News and Communications
October 22, 2015

VU-invented wireless ECG system receives FDA approval

A wireless electrocardiogram (ECG) system invented at Vanderbilt University and marketed by a Nashville company, InvisionHeart, has received U.S. Food and Drug Administration (FDA) approval.

By VUMC News and Communications
October 1, 2015

Collaboration seeks to develop new therapies for bone, other diseases

La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders.

By Leigh MacMillan
April 16, 2015

‘Challenge’ puts technology transfer ingenuity on display

A strategy for commercializing a potential new test for colon cancer that can make tumor cells “glow” won top honors at last week’s TechVenture Challenge.

By VUMC News and Communications
July 24, 2014

VU’s technology transfer efforts gain steam

Vanderbilt University signed 101 licensing agreements with industry partners in fiscal year 2014, nearly 20 more than the record total set last year.
By Bill Snyder
March 20, 2014

New system helps speed transfer of research materials

Vanderbilt University Medical Center has launched an automated system for processing and managing Material Transfer Agreements (MTAs), which govern the transfer of biological materials, chemicals, human tissue samples and other materials between institutions to facilitate academic research.
By Bill Snyder
September 26, 2013

VU’s technology commercialization efforts make strides

Over the past three years, Vanderbilt University more than quadrupled earnings from its technology commercialization efforts — to more than $24.5 million in the 2013 fiscal year that ended June 30, officials have announced.
By Bill Snyder
March 28, 2013

Technology transfer efforts bolstered by recent agreements

Last month, Vanderbilt University announced a collaboration agreement with GlaxoSmithKline, a leading pharmaceutical and consumer health care company, to develop potential new drugs for severe obesity.
By Bill Snyder
April 28, 2011

Bentley named assistant vice chancellor for Center for Technology Transfer and Commercialization

Alan Bentley, director of Commercialization for Cleveland Clinic Innovations with the Cleveland Clinic Foundation, has been named assistant vice chancellor of Technology Transfer and Intellectual Property Development.
By VUMC News and Communications